Schlich Ltd +44(0) 1903 717001 info@schlich.co.uk
Warner Lambert v Actavis – UK Court of Appeal

Warner Lambert v Actavis – UK Court of Appeal

Warner-Lambert is the proprietor of European Patent 0934061 which claims “Use of Pregablin for the preparation of a pharmaceutical composition for treating pain”. Pregablin is also used for the treatment of generalised anxiety disorder and epilepsy, although treatment...
The Bolar Exemption in the UK

The Bolar Exemption in the UK

Until now, exceptions to patent infringement in the UK were limited, so manufacturers preparing for regulatory approval risked an infringement action. Legislation will come into force in the UK on 1 October 2014 that finally provides broad exemption from patent...
From Sheep to Sleep: Supplementary Patent Protection is Extended

From Sheep to Sleep: Supplementary Patent Protection is Extended

An important consideration in the development of a pharmaceutical or other biologically active product is gaining approval from regulators to market the product. The timescales involved in gaining approval can be daunting, particularly when they are compared with the...